Designation of Oncology Target. AstraZeneca may designate one additional microRNA as a Collaboration Target (in addition to the Lead Targets) at any time during the Research Term in accordance with the following procedures (such additional Collaboration Target designated in accordance with this Section 3.4.2, the “Oncology Target”).
Appears in 1 contract
Sources: Collaboration and License Agreement (Regulus Therapeutics Inc.)
Designation of Oncology Target. AstraZeneca may designate one additional microRNA as a Collaboration Target (in addition to the Lead Targets) at any time during the Research Term in accordance with the following procedures (such additional Collaboration Target designated in accordance with this Section 3.4.2, the “Oncology Target”).time
Appears in 1 contract
Sources: Collaboration and License Agreement